tm logo
INNOVENT
Live/Registered
REGISTERED

on 24 Mar 2020

Last Applicant/ Owned by

No. 168, Dongping Street,

CN

Serial Number

79234854 filed on 16th Apr 2018

Registration Number

6015574 registered on 24th Mar 2020

in the Principal Register

Correspondent Address

Anessa Owen Kramer

Anessa Owen Kramer

39400 Woodward Avenue

Suite 101

Bloomfield Hills, MI 48304-5151

Filing Basis

No Filing Basis

Disclaimer

NO DATA

INNOVENT

Medicines for human purposes, namely, antibody preparations, protein preparations, blood preparations, hormones, enzymes, toxoids, organic compounds and hemopoietic growth factors, namely, medicines for the treatment of tumor, ophthalmologic diseases, immunological mediated diseases, metabolic diseases, blood diseases, diabetes, endocrine disease, reproductive system disease, central and periphera Read More

Classification Information


Class [005]
Pharmaceutical Products


Medicines for human purposes, namely, antibody preparations, protein preparations, blood preparations, hormones, enzymes, toxoids, organic compounds and hemopoietic growth factors, namely, medicines for the treatment of tumor, ophthalmologic diseases, immunological mediated diseases, metabolic diseases, blood diseases, diabetes, endocrine disease, reproductive system disease, central and peripheral nervous system disease, hereditary diseases, and antiviral drugs; Pharmaceutical preparations, namely, antibody preparations, protein preparation, blood preparations, hormones, enzymes, toxoids, organic compounds and hemopoietic growth factors, namely, medicines for the treatment of tumor, ophthalmologic diseases, immunological mediated diseases, metabolic diseases, blood diseases, diabetes, endocrine disease, reproductive system disease, central and peripheral nervous system disease, hereditary diseases, and antiviral drugs; Vaccines; drugs for medical purposes, namely, antibody preparations, protein preparation, blood preparations, hormones, enzymes, toxoids, organic compounds and hemopoietic growth factors, namely, medicines for the treatment of tumor, ophthalmologic diseases, immunological mediated diseases, metabolic diseases, blood diseases, diabetes, endocrine disease, reproductive system disease, central and peripheral nervous system disease, hereditary diseases, and antiviral drugs; Biological preparations for medical purposes, namely, antibody preparations, protein preparation, blood preparations, hormones, enzymes, toxoids, organic compounds and hemopoietic growth factors, namely, medicines for the treatment of tumor, ophthalmologic diseases, immunological mediated diseases, metabolic diseases, blood diseases, diabetes, endocrine disease, reproductive system disease, central and peripheral nervous system disease, hereditary diseases, and antiviral drugs; Diagnostic preparations for medical purposes; Biological tissue cultures for medical purposes; Chemical reagents for medical purposes; all of the aforesaid excluding goods in gaseous form, goods related to nitric oxide, and veterinary products, preparations, reagents, and medicine for animal health

Mark Details


Serial Number

No 79234854

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 457367

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.01.04 -

Circles with two breaks or divided in the middle

26.01.09 -

Geometric figures, objects, humans, plants or animals forming or bordering the perimeter of a circle

26.01.26 -

Spirals, coils and swirls

26.17.09 -

Curved line(s), band(s) or bar(s)

27.03.01 -

Geometric figures forming letters or numerals, including punctuation

Legal History


Show more

Status DateAction Taken
31st Jul 2020FINAL DECISION TRANSACTION PROCESSED BY IB
10th Jul 2020FINAL DISPOSITION NOTICE SENT TO IB
10th Jul 2020FINAL DISPOSITION PROCESSED
25th Jun 2020NEW REPRESENTATIVE AT IB RECEIVED
24th Jun 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
24th Mar 2020REGISTERED-PRINCIPAL REGISTER
07th Jan 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07th Jan 2020PUBLISHED FOR OPPOSITION
03rd Jan 2020NOTIFICATION PROCESSED BY IB
18th Dec 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB